| Patent application number | Description | Published |
|---|
| 20090181976 | Use of Compounds Binding to the Sigma Receptor for the Treatment of Metabolic Syndrome - The present invention refers to the use of compounds binding to the sigma receptor for the treatment of metabolic syndrome. | 07-16-2009 |
| 20090264457 | Combination of at least two 5HT6-Ligands - The present invention relates to a Combination of at least two 5HT6-Ligands of which one is a partial or agonist while the other is a full antagonist or an inverse agonist, a medicament comprising this comination, the use of the combiantion in the manufacture of a medicament for the treatment of memory disorders ADHD, and methods of treatment using the combination or its members. | 10-22-2009 |
| 20090325975 | Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain - The present invention refers to the use of compounds active on the sigma receptor for the production of a medicament for the treatment of diabetes-associated pain. | 12-31-2009 |
| 20090326014 | Use of 5-ht7 receptor agonists for the treatment of pain - The present invention refers to the use of 5-HT | 12-31-2009 |
| 20100152252 | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments - The present invention relates to heterocyclyl-substituted-ethylamino-phenyl compounds of general formula (I), wherein K-L-M-N, Z and R | 06-17-2010 |
| 20100197717 | COMBINATION OF A 5HT7 RECEPTOR LIGAND AND AN OPIOID RECEPTOR LIGAND - The present invention refers to a combination of a 5HT7 receptor ligand and an opioid receptor ligand, especially of a 5HT7 receptor agonist and an opioid receptor agonist, a medicament comprising this combination, or the use of this combination for the treatment of the symptoms of pain, the prevention or the prophylaxis of the symptoms of pain. | 08-05-2010 |
